NOVEL SELECTIVE LIGAND FOR DOPAMINE D3 RECEPTOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF

作者: Cao Yongkai , Cheon Seung Hoon , Kim Kyeong Man , Zhang Zili

DOI:

关键词:

摘要: The present invention provides a novel ligand for the dopamine D3 receptor and preparation method therefor. compound, pharmaceutically acceptable salt pharmaceutical composition or thereof are used treatment prevention of schizophrenia, neurodegenerative diseases, particularly Parkinson's disease, drug dependence, addiction, anxiety, depression, etc. features high affinity, specificity, functional selectivity. compound can be to study distribution function D2 subtype receptors mechanism diseases associated with dysfunction D2-like receptors, also disease modification hyperprolactinemia, extrapyramidal symptoms, levodopa-associated movement disorder dyskinesia.

参考文章(14)
Katalin Nogradi, Istvan Laszlovszky, Bela Kiss, Attila Bielik, Attila Horvath, Istvan Borza, Istvan Gyertyan, Janos Galambos, Tibor Acs, Gyoergy Domany, 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands ,(2002)
Giuseppe Campiani, Silvia Franceschini, Lars Siim Madsen, Stefania Butini, Caterina Fattorusso, Zia Irene Thale, Karin Sandager Nielsen, Jørgen Scheel-Krüger, Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders ,(2007)
Gabriella Ortore, Tiziano Tuccinardi, Elisabetta Orlandini, Adriano Martinelli, Different binding modes of structurally diverse ligands for human D3DAR. Journal of Chemical Information and Modeling. ,vol. 50, pp. 2162- 2175 ,(2010) , 10.1021/CI100290F
Laura Bettinetti, Stefan Löber, Harald Hübner, Peter Gmeiner, Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker. ACS Combinatorial Science. ,vol. 7, pp. 309- 316 ,(2005) , 10.1021/CC049860S
Hendrick Bothmann, Renza Roncarati, Giovanni Gaviraghi, Georg Christian Terstappenn, Chiara Ghiron, Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof ,(2005)
Marc Capet, Thierry Calmels, Nicolas Levoin, Denis Danvy, Isabelle Berrebi-Bertrand, Holger Stark, Jean-Charles Schwartz, Jeanne-Marie Lecomte, Improving selectivity of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. ,vol. 26, pp. 885- 888 ,(2016) , 10.1016/J.BMCL.2015.12.068
Eva Againe Csongor, Bela Kiss, Eva Schmidt, Norbert Antal Kirschner, Istvan Gyertyan, Metabolites of (thio)carbamoyl-cyclohexane derivatives ,(2008)
Oliver Nayler, Jörg Velker, Christoph Binkert, Boris Mathys, Hamed Aissaoui, Thomas Weller, Michael Scherz, Claus Müller, Martine Clozel, Piperazine-alkyl-ureido derivatives ,(2004)
Bela Kiss, Katalin Saghy, Eva Schmidt, Istvan Gyertyan, Janos Galambos, Gyorgy Domany, Eva Againe Csongor, Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists ,(2006)